-
Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial
En-CPhI.CN
November 11, 2019
Merck and Pfizer Inc. announced topline results of the Phase III JAVELIN Gastric 100 study evaluating avelumab as first-line maintenance therapy following induction chemotherapy in patients with unresectable ...
-
Pfizer amps up gene therapy manufacturing with another North Carolina facility
fiercepharma
September 26, 2019
Pfizer has several programs for possible genetic cures it is shepherding through its pipeline, including one with partner Sangamo Therapeutics for treating hemophilia A and another for Duchenne muscular dystrophy.
-
Pfizer invests half billion dollars to advance state-of-the-art gene therapy facility in Sanford, North Carolina
worldpharmanews
September 02, 2019
Pfizer announced an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford...
-
Pfizer, Astellas rocket toward broader Xtandi use with FDA 'priority' tag
fiercepharma
August 25, 2019
Pfizer and Astellas are chasing a new nod for prostate cancer drug Xtandi, and thanks to a new move from the FDA, they might not have to wait that long.
-
Pfizer commits $500m to expand gene therapy facility
pharmaceutical-technology
August 23, 2019
Pfizer has announced plans to invest an additional $500m for the expansion of a gene therapy manufacturing facility in Sanford, North Carolina, US.
-
Pfizer adds $500M to gene therapy manufacturing plant where it will hire 300 workers
fiercepharma
August 22, 2019
Pfizer, which is in a race with competitors for its initial gene therapies, is shifting its production efforts into overdrive. The company will inject another $500 million into a manufacturing plant in North Carolina and says it will hire another 300 work
-
The Pfizer Foundation invests in 20 organizations tackling infectious diseases and antimicrobial resistance
worldpharmanews
August 22, 2019
The Pfizer Foundation announced 20 grants* to help non-governmental organizations (NGOs), non-profits and social enterprises address critical health challenges related to infectious diseases...
-
Pfizer Foundation Invests in 20 Organizations Tackling Infectious Diseases and Antimicrobial Resistance
americanpharmaceuticalreview
August 22, 2019
The Pfizer Foundation has announced 20 grants to help non-governmental organizations (NGOs), non-profits and social enterprises address critical health challenges related to infectious diseases ...
-
Pfizer Invests $500M in Gene Therapy Facility
contractpharma
August 22, 2019
The Sanford, NC site to support continuing investment in gene therapy R&D .
-
Two lots of migraine medication have been recalled
europeanpharmaceuticalreview
August 20, 2019
Pfizer has volountarily recalled the migraine medication Relpax because of the potential presence of Genus Pseudomonas and Burkholderia.